These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 28803708

  • 1. Anti-phospholipid syndrome: Current opinion on mechanisms involved, laboratory characterization and diagnostic aspects.
    Amiral J, Peyrafitte M, Dunois C, Vissac AM, Seghatchian J.
    Transfus Apher Sci; 2017 Aug; 56(4):612-625. PubMed ID: 28803708
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Antiphospholipid antibodies: clinical significance and biological diagnosis].
    Arnoux D, Boutière B, Sanmarco M.
    Ann Biol Clin (Paris); 2000 Aug; 58(5):557-74. PubMed ID: 11022099
    [Abstract] [Full Text] [Related]

  • 4. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW, Rangarajan S, Savidge GF.
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [Abstract] [Full Text] [Related]

  • 5. Coagulation tests and anti-phospholipid antibodies in patients positive for lupus anticoagulant.
    Sakakura M, Wada H, Watanabe R, Mamamuro M, Okugawa Y, Nakasaki T, Nakase T, Wakita Y, Minamikawa K, Mori Y, Nshikawa M, Shiku H.
    Clin Appl Thromb Hemost; 2000 Jul; 6(3):144-50. PubMed ID: 10898274
    [Abstract] [Full Text] [Related]

  • 6. Clinical importance of positive test results for lupus anticoagulant and anticardiolipin antibodies.
    Proven A, Bartlett RP, Moder KG, Chang-Miller A, Cardel LK, Heit JA, Homburger HA, Petterson TM, Christianson TJ, Nichols WL.
    Mayo Clin Proc; 2004 Apr; 79(4):467-75. PubMed ID: 15065611
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O, Crippa L, Della Valle P, Sabbadini MG, Viganò D'Angelo S, D'Angelo A.
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic accuracy of silica clotting time method for lupus anticoagulant in a clinical population with various symptoms of antiphospholipid syndrome.
    Averina M, Johannesen S, Brox J.
    Lupus; 2016 Apr; 25(4):418-22. PubMed ID: 26612052
    [Abstract] [Full Text] [Related]

  • 10. Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA.
    Tripodi A, Chantarangkul V, Clerici M, Mannucci PM.
    Thromb Haemost; 2002 Oct; 88(4):583-6. PubMed ID: 12362227
    [Abstract] [Full Text] [Related]

  • 11. Laboratory identification of lupus anticoagulants using the combination of activated partial thromboplastin time and Russell's viper venom at two phospholipid concentrations.
    Akkawat B, Chantarangkul V, Rojnuckarin P, Juntiang J.
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S451-8. PubMed ID: 12930024
    [Abstract] [Full Text] [Related]

  • 12. Studies on the interaction of placental anticoagulant protein I, beta 2 glycoprotein 1, and antiphospholipid antibodies in the prothrombinase reaction and in the solid phase anticardiolipin assays.
    Pierangeli SS, Dean J, Goldsmith GH, Branch DW, Gharavi A, Harris EN.
    J Lab Clin Med; 1996 Aug; 128(2):194-201. PubMed ID: 8765215
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Use of a new silica clotting time for diagnosing lupus anticoagulant in patients who meet the clinical criteria for antiphospholipid syndrome.
    Grypiotis P, Ruffatti A, Pengo V, Tonello M, Biasiolo A, Zamboni D, Cavazzana A, Todesco S.
    J Clin Lab Anal; 2006 Aug; 20(1):15-8. PubMed ID: 16470527
    [Abstract] [Full Text] [Related]

  • 16. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J.
    Verh K Acad Geneeskd Belg; 2000 Aug; 62(5):353-72. PubMed ID: 11144685
    [Abstract] [Full Text] [Related]

  • 17. Anti-beta2-glycoprotein I and anti-prothrombin antibodies in patients with the 'antiphospholipid' syndrome: immunological specificity and clotting profiles.
    Kandiah DA, Krilis SA.
    Lupus; 1998 Aug; 7(5):323-32. PubMed ID: 9696136
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.